End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-07 EDT
|
5-day change
|
1st Jan Change
|
8.01
CNY
|
+0.75%
|
|
+2.04%
|
-20.85%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8,528
|
7,013
|
6,610
|
9,296
|
7,541
|
8,662
|
Enterprise Value (EV)
1 |
7,803
|
6,160
|
5,616
|
8,593
|
6,538
|
7,888
|
P/E ratio
|
25.8
x
|
36.3
x
|
24.3
x
|
34.3
x
|
21
x
|
29.1
x
|
Yield
|
4.08%
|
4.79%
|
5.08%
|
3.68%
|
4.54%
|
3.95%
|
Capitalization / Revenue
|
2.73
x
|
2.2
x
|
1.86
x
|
2.46
x
|
2.49
x
|
2.93
x
|
EV / Revenue
|
2.5
x
|
1.93
x
|
1.58
x
|
2.27
x
|
2.16
x
|
2.66
x
|
EV / EBITDA
|
19.8
x
|
16.1
x
|
10.8
x
|
17.5
x
|
18.6
x
|
19.8
x
|
EV / FCF
|
59.4
x
|
10
x
|
12.8
x
|
88.5
x
|
15.1
x
|
1,028
x
|
FCF Yield
|
1.68%
|
9.97%
|
7.79%
|
1.13%
|
6.63%
|
0.1%
|
Price to Book
|
1.95
x
|
1.76
x
|
1.72
x
|
2.34
x
|
1.89
x
|
2.19
x
|
Nbr of stocks (in thousands)
|
869,354
|
839,933
|
839,933
|
855,942
|
855,942
|
855,942
|
Reference price
2 |
9.810
|
8.350
|
7.870
|
10.86
|
8.810
|
10.12
|
Announcement Date
|
19-04-29
|
20-04-29
|
21-03-19
|
22-04-22
|
23-04-28
|
24-04-24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,123
|
3,184
|
3,560
|
3,784
|
3,033
|
2,961
|
EBITDA
1 |
395.1
|
382.1
|
519.2
|
491.1
|
351.2
|
398.4
|
EBIT
1 |
290.2
|
284.8
|
413.2
|
379.9
|
233.3
|
281.2
|
Operating Margin
|
9.29%
|
8.95%
|
11.61%
|
10.04%
|
7.69%
|
9.5%
|
Earnings before Tax (EBT)
1 |
382.4
|
265.5
|
351.4
|
356.7
|
457
|
350.6
|
Net income
1 |
327.3
|
192.1
|
272.3
|
270.7
|
359.4
|
297.4
|
Net margin
|
10.48%
|
6.04%
|
7.65%
|
7.15%
|
11.85%
|
10.04%
|
EPS
2 |
0.3800
|
0.2300
|
0.3242
|
0.3167
|
0.4198
|
0.3475
|
Free Cash Flow
1 |
131.4
|
614.3
|
437.7
|
97.07
|
433.8
|
7.675
|
FCF margin
|
4.21%
|
19.3%
|
12.3%
|
2.57%
|
14.3%
|
0.26%
|
FCF Conversion (EBITDA)
|
33.27%
|
160.78%
|
84.31%
|
19.76%
|
123.52%
|
1.93%
|
FCF Conversion (Net income)
|
40.15%
|
319.73%
|
160.73%
|
35.86%
|
120.72%
|
2.58%
|
Dividend per Share
2 |
0.4000
|
0.4000
|
0.4000
|
0.4000
|
0.4000
|
0.4000
|
Announcement Date
|
19-04-29
|
20-04-29
|
21-03-19
|
22-04-22
|
23-04-28
|
24-04-24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
725
|
853
|
994
|
702
|
1,003
|
774
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
131
|
614
|
438
|
97.1
|
434
|
7.68
|
ROE (net income / shareholders' equity)
|
7.33%
|
4.5%
|
6.81%
|
6.79%
|
8.95%
|
7.46%
|
ROA (Net income/ Total Assets)
|
3.26%
|
3.51%
|
5.18%
|
4.59%
|
2.78%
|
3.31%
|
Assets
1 |
10,039
|
5,479
|
5,260
|
5,893
|
12,946
|
8,981
|
Book Value Per Share
2 |
5.020
|
4.750
|
4.580
|
4.640
|
4.660
|
4.620
|
Cash Flow per Share
2 |
0.6400
|
0.3600
|
0.9300
|
0.9400
|
1.270
|
0.7900
|
Capex
1 |
142
|
151
|
80.9
|
207
|
96.8
|
72.8
|
Capex / Sales
|
4.55%
|
4.74%
|
2.27%
|
5.48%
|
3.19%
|
2.46%
|
Announcement Date
|
19-04-29
|
20-04-29
|
21-03-19
|
22-04-22
|
23-04-28
|
24-04-24
|
|
1st Jan change
|
Capi.
|
---|
| -20.85% | 943M | | +43.33% | 6.34B | | -16.78% | 4.51B | | -6.93% | 3.29B | | +3.89% | 3.2B | | -0.88% | 2.59B | | +46.64% | 2.09B | | -5.34% | 1.76B | | +1.60% | 1.7B | | -7.31% | 1.62B |
Alternative Medicine
|